| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Bardia Nourbakhsh, Christian Cordano, Carlo Asteggiano, Klemens Ruprecht, Carolin Otto, Alice Rutatangwa, Allysa Lui, Janace Hart, Eoin P Flanagan, Judith A James, Emmanuelle Wauban. Multiple Sclerosis Is Rare in Epstein-Barr Virus-Seronegative Children with Central Nervous System Inflammatory Demyelination. Annals of neurology. vol 89. issue 6. 2021-08-02. PMID:33704815. |
when re-evaluating 25 ebv-seronegative children out of 189 pediatric patients with a diagnosis of clinically isolated syndrome/ms, we found anti-myelin oligodendrocyte glycoprotein (mog) antibody in 11 of 25 (44%) ebv-seronegative but only 9 of 164 (5.5%, p < 0.001) ebv-seropositive patients. |
2021-08-02 |
2023-08-13 |
Not clear |
| Ran Tao, Chuan Qin, Man Chen, Hai-Han Yu, Long-Jun Wu, Bi-Tao Bu, Dai-Shi Tia. Unilateral cerebral cortical encephalitis with epilepsy: a possible special phenotype of MOG antibody-associated disorders. The International journal of neuroscience. vol 130. issue 11. 2021-07-29. PMID:31971044. |
myelin oligodendrocyte glycoprotein (mog) antibody-related encephalomyelitis is an increasingly recognized entity with heterogeneity in phenotype. |
2021-07-29 |
2023-08-13 |
Not clear |
| L Mohammadnejad, A Zare Mirakabadi, Sh Oryan, Sh Jelodar Dezfoul. Anti-inflammatory Activity of Caspian Cobra (Naja naja oxiana) Snake Venom on the Serum Level of Interleukin-27 and Histopathological Changes in Myelin Oligodendrocyte Glycoprotein-experimental Autoimmune Encephalomyelitisinduced Mice. Archives of Razi Institute. vol 75. issue 4. 2021-07-29. PMID:33403844. |
groups 2 and 3 received flank injection with the emulsion of myelin oligodendrocyte glycoprotein (mog 35-55), as well as complete freund adjuvant, followed by the administration of pertussis toxin. |
2021-07-29 |
2023-08-13 |
mouse |
| Dana Rebecca Siegel, Thanh-Ha Luu, Malgorzata E Skaznik-Wikie. Primary Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-associated Optic Neuritis Presenting after a Frozen Embryo Transfer. Journal of human reproductive sciences. vol 14. issue 2. 2021-07-29. PMID:34316239. |
myelin oligodendrocyte glycoprotein (mog)-immunoglobulin g-associated optic neuritis (on) is a newly recognized antibody-mediated demyelinating disease of the central nervous system, resulting in acute visual loss and pain with eye movement. |
2021-07-29 |
2023-08-13 |
Not clear |
| Jonathan Ciron, Alvaro Cobo-Calvo, Bertrand Audoin, Bertrand Bourre, David Brassat, Mikael Cohen, Nicolas Collongues, Romain Deschamps, Françoise Durand-Dubief, David Laplaud, Elisabeth Maillart, Caroline Papeix, Hélène Zephir, Matthieu Bereau, Bruno Brochet, Clarisse Carra-Dallière, Nathalie Derache, Clarisse Gagou-Scherer, Carole Henry, Philippe Kerschen, Guillaume Mathey, Nicolas Maubeuge, Aude Maurousset, Alexis Montcuquet, Thibault Moreau, Christophe Prat, Frédéric Taithe, Eric Thouvenot, Ayman Tourbah, Fabien Rollot, Sandra Vukusic, Romain Marignie. Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study. Multiple sclerosis (Houndmills, Basingstoke, England). vol 26. issue 8. 2021-07-28. PMID:31148523. |
we aim to (1) determine the frequency and distinctive features of short myelitis (sm) and longitudinally extensive transverse myelitis (letm) in a cohort of adults with myelin oligodendrocyte glycoprotein (mog)-antibody (ab)-associated myelitis and (2) determine baseline prognostic factors among mog-ab-positive patients whose disease started with myelitis. |
2021-07-28 |
2023-08-13 |
Not clear |
| Sven Jarius, Hannah Pellkofer, Nadja Siebert, Mirjam Korporal-Kuhnke, Martin W Hümmert, Marius Ringelstein, Paulus S Rommer, Ilya Ayzenberg, Klemens Ruprecht, Luisa Klotz, Nasrin Asgari, Tobias Zrzavy, Romana Höftberger, Rafik Tobia, Mathias Buttmann, Kai Fechner, Kathrin Schanda, Martin Weber, Susanna Asseyer, Jürgen Haas, Christian Lechner, Ingo Kleiter, Orhan Aktas, Corinna Trebst, Kevin Rostasy, Markus Reindl, Tania Kümpfel, Friedemann Paul, Brigitte Wildeman. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients. Journal of neuroinflammation. vol 17. issue 1. 2021-07-21. PMID:32883348. |
cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (mog) antibodies. |
2021-07-21 |
2023-08-13 |
human |
| Sven Jarius, Christian Lechner, Eva M Wendel, Matthias Baumann, Markus Breu, Mareike Schimmel, Michael Karenfort, Adela Della Marina, Andreas Merkenschlager, Charlotte Thiels, Astrid Blaschek, Michela Salandin, Steffen Leiz, Frank Leypoldt, Alexander Pschibul, Annette Hackenberg, Andreas Hahn, Steffen Syrbe, Jurgis Strautmanis, Martin Häusler, Peter Krieg, Astrid Eisenkölbl, Johannes Stoffels, Matthias Eckenweiler, Ilya Ayzenberg, Jürgen Haas, Romana Höftberger, Ingo Kleiter, Mirjam Korporal-Kuhnke, Marius Ringelstein, Klemens Ruprecht, Nadja Siebert, Kathrin Schanda, Orhan Aktas, Friedemann Paul, Markus Reindl, Brigitte Wildemann, Kevin Rostás. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients. Journal of neuroinflammation. vol 17. issue 1. 2021-07-21. PMID:32883358. |
cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (mog) antibodies. |
2021-07-21 |
2023-08-13 |
human |
| Sa-Ying Zhu, Jing Peng, Lei-Lei Mao, Xiao-Lu Deng, Ci-Liu Zhang, Li-Fen Yang, Fei Yin, Fang H. [Recurrence factors for myelin oligodendrocyte glycoprotein antibody disease in children and the effect of recurrence prevention regimens]. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics. vol 23. issue 7. 2021-07-19. PMID:34266531. |
to study the clinical features and recurrence factors of myelin oligodendrocyte glycoprotein (mog) antibody disease in children and the effect of recurrence prevention regimens. |
2021-07-19 |
2023-08-13 |
Not clear |
| Friederike Held, Sudhakar Reddy Kalluri, Achim Berthele, Ana-Katharina Klein, Markus Reindl, Bernhard Hemme. Frequency of myelin oligodendrocyte glycoprotein antibodies in a large cohort of neurological patients. Multiple sclerosis journal - experimental, translational and clinical. vol 7. issue 2. 2021-07-16. PMID:34262784. |
myelin oligodendrocyte glycoprotein (mog) antibody disease (mog-ad) is recognized as a distinct nosological entity. |
2021-07-16 |
2023-08-13 |
Not clear |
| Andres Server Alonso, Tomas Sakinis, Helle Cecilie V Pfeiffer, Inger Sandvig, Jon Barlinn, Pål B Marthinse. Understanding Pediatric Neuroimmune Disorder Conflicts: A Neuroradiologic Approach in the Molecular Era. Radiographics : a review publication of the Radiological Society of North America, Inc. vol 40. issue 5. 2021-07-14. PMID:32735475. |
the authors focus on pediatric-onset myelin oligodendrocyte glycoprotein (mog) antibody-associated disease, which is a new entity in the spectrum of inflammatory demyelinating diseases, distinct from both multiple sclerosis (ms) and anti-aquaporin-4 (aqp4) antibody neuromyelitis optica spectrum disorders (nmosds). |
2021-07-14 |
2023-08-13 |
Not clear |
| Laetitia Pouzol, Nadège Baumlin, Anna Sassi, Mélanie Tunis, Julia Marrie, Enrico Vezzali, Hervé Farine, Ulrich Mentzel, Marianne M Martini. ACT-1004-1239, a first-in-class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 35. issue 3. 2021-07-13. PMID:33595155. |
the effect of act-1004-1239 was evaluated in the myelin oligodendrocyte glycoprotein (mog)-induced experimental autoimmune encephalomyelitis (eae) and the cuprizone-induced demyelination mouse models. |
2021-07-13 |
2023-08-13 |
mouse |
| Shunsuke Yoshimura, Shinsuke Nakagawa, Toshiyuki Takahashi, Keiko Tanaka, Akira Tsujin. FTY720 Exacerbates Blood-Brain Barrier Dysfunction Induced by IgG Derived from Patients with NMO and MOG Disease. Neurotoxicity research. vol 39. issue 4. 2021-07-13. PMID:33999356. |
neuromyelitis optica (nmo) and myelin oligodendrocyte glycoprotein (mog) antibody-related disease (mog disease) are inflammatory demyelinating diseases of the central nervous system (cns). |
2021-07-13 |
2023-08-13 |
rat |
| Matthew C Mason, Dario A Marotta, Hassan Kesserwan. Isolated Double-Positive Optic Neuritis: A Case of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody Seropositivity. Cureus. vol 13. issue 6. 2021-07-13. PMID:34249541. |
these conditions are usually accompanied by multi-level spinal cord demyelination, and notably, they are typically positive for either nmo or myelin oligodendrocyte glycoprotein (mog) autoantibodies, but rarely both. |
2021-07-13 |
2023-08-13 |
Not clear |
| Joseph H Choe, Payal B Watchmaker, Milos S Simic, Ryan D Gilbert, Aileen W Li, Nira A Krasnow, Kira M Downey, Wei Yu, Diego A Carrera, Anna Celli, Juhyun Cho, Jessica D Briones, Jason M Duecker, Yitzhar E Goretsky, Ruth Dannenfelser, Lia Cardarelli, Olga Troyanskaya, Sachdev S Sidhu, Kole T Roybal, Hideho Okada, Wendell A Li. SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma. Science translational medicine. vol 13. issue 591. 2021-07-12. PMID:33910979. |
a synnotch receptor that recognizes a specific priming antigen, such as the heterogeneous but tumor-specific glioblastoma neoantigen epidermal growth factor receptor splice variant iii (egfrviii) or the central nervous system (cns) tissue-specific antigen myelin oligodendrocyte glycoprotein (mog), can be used to locally induce expression of a car. |
2021-07-12 |
2023-08-13 |
mouse |
| C L de Mol, Yym Wong, E D van Pelt, Bha Wokke, Tam Siepman, R F Neuteboom, D Hamann, R Q Hintze. The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults. Multiple sclerosis (Houndmills, Basingstoke, England). vol 26. issue 7. 2021-07-09. PMID:31094288. |
the aim of this study was to assess the dutch nationwide incidence of myelin oligodendrocyte glycoprotein (mog)-igg-associated acquired demyelinating syndromes (ads) and to describe the clinical and serological characteristics of these patients. |
2021-07-09 |
2023-08-13 |
Not clear |
| Fiona Costello, John J Che. The role of optical coherence tomography in the diagnosis of afferent visual pathway problems: A neuroophthalmic perspective. Handbook of clinical neurology. vol 178. 2021-07-09. PMID:33832689. |
on a more pragmatic level, oct is used in the clinical arena to diagnose on associated with: ms, neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein (mog) antibody associated disease (mogad). |
2021-07-09 |
2023-08-13 |
Not clear |
| Mena Farag, Naomi Sibtain, James Burge, Vinay Chaudhry, Eli Silbe. Atypical inflammatory demyelinating syndrome with central and peripheral nerve involvement. Multiple sclerosis and related disorders. vol 51. 2021-07-07. PMID:34049139. |
oligoclonal bands (ocbs) were matched and serum antibodies against aquaporin-4 (aqp-4) and myelin oligodendrocyte glycoprotein (mog) were negative. |
2021-07-07 |
2023-08-13 |
Not clear |
| Amy Li Safadi, Cory J Myers, Nancy N Hu, Benjamin Osborn. Conus involvement and leptomeningeal enhancement in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: A case report. Multiple sclerosis and related disorders. vol 52. 2021-07-06. PMID:34015641. |
we discuss the factors that complicated a timely diagnosis, including her atypical radiographic features and an initially negative cell-based assay for myelin oligodendrocyte glycoprotein (mog) and aquaporin-4 (aqp4) antibodies. |
2021-07-06 |
2023-08-13 |
Not clear |
| Min Sung Kang, Min Kyoung Kim, Ye Eun Kim, Ji Hyun Kim, Byoung Joon Kim, Hye Lim Le. Two cases of myelin oligodendrocyte glycoprotein antibody-associated disease presenting with Cauda Equina Syndrome without conus myelitis. Multiple sclerosis and related disorders. vol 52. 2021-07-06. PMID:34023773. |
myelin oligodendrocyte glycoprotein antibody-associated disorder (mogad) is a central nervous system inflammatory disorder associated with mog antibodies. |
2021-07-06 |
2023-08-13 |
Not clear |
| Weibi Chen, Qian Li, Ting Wang, Linlin Fan, Lehong Gao, Zhaoyang Huang, Yicong Lin, Qin Xue, Gang Liu, Yingying Su, Yan Zhan. Overlapping syndrome of anti-N-methyl-D-aspartate receptor encephalitis and anti-myelin oligodendrocyte glycoprotein inflammatory demyelinating diseases: A distinct clinical entity? Multiple sclerosis and related disorders. vol 52. 2021-07-06. PMID:34034214. |
the co-existence of anti-n-methyl-d-aspartate receptor encephalitis (nmdare) and anti-myelin oligodendrocyte glycoprotein (mog) antibody disease has sparsely been reported, which needs to be investigated. |
2021-07-06 |
2023-08-13 |
Not clear |